Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1996. Start Trial.
Date Value
October 02, 2026 5.597
October 01, 2026 5.626
September 30, 2026 5.712
September 29, 2026 5.754
September 28, 2026 5.847
September 25, 2026 5.754
September 24, 2026 5.630
September 23, 2026 5.597
September 22, 2026 5.698
September 21, 2026 5.732
September 18, 2026 5.772
September 17, 2026 5.752
September 16, 2026 5.822
September 15, 2026 5.834
September 14, 2026 5.868
September 11, 2026 5.825
September 10, 2026 5.835
September 09, 2026 5.896
September 08, 2026 5.922
September 04, 2026 6.116
September 03, 2026 6.233
September 02, 2026 6.193
September 01, 2026 6.126
August 31, 2026 6.116
August 28, 2026 6.094
Date Value
August 27, 2026 6.128
August 26, 2026 6.185
August 25, 2026 6.217
August 24, 2026 6.159
August 21, 2026 6.134
August 20, 2026 5.993
August 19, 2026 6.189
August 18, 2026 6.046
August 17, 2026 5.916
August 14, 2026 5.843
August 13, 2026 5.918
August 12, 2026 5.831
August 11, 2026 5.823
August 10, 2026 5.935
August 07, 2026 5.924
August 06, 2026 5.872
August 05, 2026 5.824
August 04, 2026 6.031
August 03, 2026 5.993
July 31, 2026 5.978
July 30, 2026 5.937
July 29, 2026 5.776
July 28, 2026 5.822
July 27, 2026 5.726
July 24, 2026 5.684

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Johnson & Johnson 7.256
Eli Lilly & Co. 31.76
Merck & Co., Inc. 8.495
Pfizer Inc. 1.860
AstraZeneca PLC 10.28

Price to Book Value Related Metrics